2023-09-01 12:45:33 ET
More on Bavarian Nordic
- Bavarian Nordic A/S ( OTCPK:BVNKF ) Q2 2023 Earnings Call Transcript
- Bavarian Nordic receives $120m contract for manufacturing of smallpox and mpox vaccine from U.S. government
- Bavarian Nordic monkeypox vaccine Jynneos more effective with two doses
- Emergent BioSolutions to offload travel health business to Bavarian Nordic for $380M
- Bavarian Nordic enters $83M agreement with the U.S. DOD to develop Equine Encephalitis Virus vaccine
- Bavarian Nordic to supply up to 2M doses of monkeypox vaccine to EU
For further details see:
Bavarian Nordic drops COVID booster from pipeline